Doxycycline Hyclate Tablet, Delayed Release — FDA Drug Shortage

To Be Discontinued — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Doxycycline Hyclate Tablet, Delayed Release (tablet) from Teva Pharmaceuticals USA, Inc. with status To Be Discontinued. The shortage was first posted on Jul 30, 2026.

Shortage details

Status
To Be Discontinued
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
0591-4575-60
Dosage Form
Tablet
Presentation
Doxycycline Hyclate, Tablet, Delayed Release, 200 mg (NDC 0591-4575-60)
Initial Posting
Jul 30, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.